These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

191 related articles for article (PubMed ID: 11868093)

  • 1. Tissue harmonic and contrast-specific imaging: back to gray scale in ultrasound.
    Lencioni R; Cioni D; Bartolozzi C
    Eur Radiol; 2002 Jan; 12(1):151-65. PubMed ID: 11868093
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Harmonic hepatic US with microbubble contrast agent: initial experience showing improved characterization of hemangioma, hepatocellular carcinoma, and metastasis.
    Wilson SR; Burns PN; Muradali D; Wilson JA; Lai X
    Radiology; 2000 Apr; 215(1):153-61. PubMed ID: 10751481
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Ultrasound contrast agents: basic principles.
    Calliada F; Campani R; Bottinelli O; Bozzini A; Sommaruga MG
    Eur J Radiol; 1998 May; 27 Suppl 2():S157-60. PubMed ID: 9652516
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Tissue harmonic imaging techniques: physical principles and clinical applications.
    Desser TS; Jeffrey RB
    Semin Ultrasound CT MR; 2001 Feb; 22(1):1-10. PubMed ID: 11300583
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Focal hepatic lesions: evaluation with contrast-enhanced gray-scale harmonic US.
    Jang HJ; Lim HK; Lee WJ; Kim SH; Kim MJ; Choi D; Lee SJ; Lim JH
    Korean J Radiol; 2003; 4(2):91-100. PubMed ID: 12845304
    [TBL] [Abstract][Full Text] [Related]  

  • 6. On the feasibility of real-time, in vivo harmonic imaging with proteinaceous microspheres.
    Forsberg F; Goldberg BB; Liu JB; Merton DA; Rawool NM
    J Ultrasound Med; 1996 Dec; 15(12):853-60; quiz 861-2. PubMed ID: 8947861
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Differential patterns of contrast enhancement in different focal liver lesions after injection of the microbubble US contrast agent SonoVue.
    Quaia E; Degobbis F; Tona G; Mosconi E; Bertolotto M; Pozzi Mucelli R
    Radiol Med; 2004 Mar; 107(3):155-65. PubMed ID: 15031681
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Ultrasonographic detection of focal liver lesions: increased sensitivity and specificity with microbubble contrast agents.
    Hohmann J; Albrecht T; Hoffmann CW; Wolf KJ
    Eur J Radiol; 2003 May; 46(2):147-59. PubMed ID: 12714231
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Early assessment of the therapeutic response to radio frequency ablation for hepatocellular carcinoma: utility of gray scale harmonic ultrasonography with a microbubble contrast agent.
    Choi D; Lim HK; Lee WJ; Kim SH; Kim YH; Kim SH; Lim JH
    J Ultrasound Med; 2003 Nov; 22(11):1163-72. PubMed ID: 14620886
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Characterization of focal liver lesions with contrast-specific US modes and a sulfur hexafluoride-filled microbubble contrast agent: diagnostic performance and confidence.
    Quaia E; Calliada F; Bertolotto M; Rossi S; Garioni L; Rosa L; Pozzi-Mucelli R
    Radiology; 2004 Aug; 232(2):420-30. PubMed ID: 15286314
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Focal hepatic lesions: contrast-enhancement patterns at pulse-inversion harmonic US using a microbubble contrast agent.
    Kim EA; Yoon KH; Lee YH; Kim HW; Juhng SK; Won JJ
    Korean J Radiol; 2003; 4(4):224-33. PubMed ID: 14726639
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of Gray-Scale Ultrasonography Immediate Post-Contrast on Characterization of Focal Liver Lesions.
    Yang W; Chen MH; Wu W; Dai Y; Fan ZH
    Biomed Res Int; 2015; 2015():193178. PubMed ID: 26090387
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Characterization of focal liver lesions with contrast-enhanced low MI real time ultrasound and SonoVue].
    Hohmann J; Skrok J; Puls R; Albrecht T
    Rofo; 2003 Jun; 175(6):835-43. PubMed ID: 12811698
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clinical management of focal liver lesions: the key role of real-time contrast-enhanced US.
    Lencioni R; Della Pina C; Crocetti L; Bozzi E; Cioni D
    Eur Radiol; 2007 Dec; 17 Suppl 6():F73-9. PubMed ID: 18376460
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Liver lesions: intermittent second-harmonic gray-scale US can increase conspicuity with microbubble contrast material-early experience.
    Heckemann RA; Cosgrove DO; Blomley MJ; Eckersley RJ; Harvey CJ; Mine Y
    Radiology; 2000 Aug; 216(2):592-6. PubMed ID: 10924591
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Contrast-enhanced, wide-band harmonic gray scale imaging of hepatocellular carcinoma: correlation with helical computed tomographic findings.
    Numata K; Tanaka K; Kiba T; Saito S; Ikeda M; Hara K; Tanaka N; Morimoto M; Iwase S; Sekihara H
    J Ultrasound Med; 2001 Feb; 20(2):89-98. PubMed ID: 11211141
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Comparison of contrast harmonic imaging in B-mode with stimulated acoustic emission, conventional B-mode US and spiral CT in the detection of focal liver lesions].
    Beissert M; Jenett M; Keberle M; Kessler C; Klein D; Beer M; Hahn D
    Rofo; 2000 Apr; 172(4):361-6. PubMed ID: 10961221
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Harmonic ultrasound: a review.
    Ziegler L; O'Brien RT
    Vet Radiol Ultrasound; 2002; 43(6):501-9. PubMed ID: 12502102
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Contrast-enhanced harmonic gray-scale sonographic-histologic correlation of the therapeutic effects of transcatheter arterial chemoembolization in patients with hepatocellular carcinoma.
    Morimoto M; Shirato K; Sugimori K; Kokawa A; Tomita N; Saito T; Imada T; Tanaka N; Nozawa A; Numata K; Tanaka K
    AJR Am J Roentgenol; 2003 Jul; 181(1):65-9. PubMed ID: 12818831
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Corona enhancement in ultrasonographical post-vascular phase images with microbubble contrast agent: a novel specific sign for hepatocellular carcinomas.
    Yamamoto K; Nakanishi S; Fuke H; Hashimoto A; Shimizu A; Hamataki T; Shiraki K
    Oncol Rep; 2006 Apr; 15(4):785-90. PubMed ID: 16525659
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.